The vascular endothelial growth factor inhibitor market is anticipated to grow at a significant CAGR of 8.3% during the forecast period (2022-2028). Vascular endothelial growth factor has proved useful in cancer therapy. Vascular endothelial growth factor signaling pathway inhibitors are approved for the treatment of different forms of tumor which are diagnosed after biopsy. After […]
